Brief: Sandoz And Aequus Agree To 1-Year Extension On Vistitan In Canada
11/01/2022 14:17
Jan 11 (Reuters) -
* SANDOZ AND AEQUUS AGREE TO 1-YEAR EXTENSION ON VISTITAN IN
CANADA
Source text for Eikon: ID:nGNX350Rjz
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange